trending Market Intelligence /marketintelligence/en/news-insights/trending/JQfhtWWwYN1LjqrNICLjJA2 content esgSubNav
In This List

Immunomedics secures patent for investigational cancer treatment

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Immunomedics secures patent for investigational cancer treatment

Immunomedics Inc. secured patent coverage for its IMMU-140 cancer treatment in the U.S.

The protection will last until July 2033 and will cover the use of IMMU-140 in multiple cancer types, including melanoma, kidney or liver.

IMMU-140 is an investigational drug that is currently under development.